CIK 0001625297 · Large accelerated filer
Supernus, Inc.
Sign in to watch- Tickers
- INDV SUPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 412520873
- Phone
- 804-379-1090
- Business address
- 9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
- Former names
- Indivior Pharmaceuticals, Inc., INDIVIOR PLC
Securities
- INDV Common stock Nasdaq
- SUPN Common Stock Nasdaq
- Open-market buys, last 90 days
- $53,535
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$53,535. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +1,155 | 1,155 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +1,155 | 1,155 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +1,540 | 1,540 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +1,886 | 1,886 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +1,886 | 1,886 | ||
| 2026-11-02 | Rubin Jonathan SVP, Chief Medical Officer | Other acquisition · Restricted Stock Units | +1,617 | 1,617 | ||
| 2026-08-27 | Anderson Woodrow D Chief Accounting Officer | Purchase | +1,500 | $35.69 | $54K | 27,638 |
| 2026-08-05 | Anderson Woodrow D Chief Accounting Officer | Purchase | +1,500 | $36.28 | $54K | 26,138 |
| 2026-07-10 | Heidbreder Christian Chief Scientific Officer | Sale 10b5-1 | −18,586 | $41.14 | $765K | 209,337 |
| 2026-06-22 | Ciaffoni Joseph Chief Executive Officer | Option exercise | +1,266,903 | 1,402,879 | ||
| 2026-06-22 | Ciaffoni Joseph Chief Executive Officer | Shares withheld for taxes | −612,549 | $38.32 | $23.5M | 790,330 |
| 2026-06-22 | Ciaffoni Joseph Chief Executive Officer | Option exercise · Performance Stock Units | −1,266,903 | 0 | ||
| 2026-06-11 | Heidbreder Christian Chief Scientific Officer | Sale 10b5-1 | −18,586 | $38.06 | $707K | 227,923 |
| 2026-06-08 | Preblick Ryan Chief Financial Officer | Sale 10b5-1 | −36,000 | $37.70 | $1.4M | 284,751 |
| 2026-05-13 | Humphreys Keith Director | Grant or award | +6,518 | 16,042 | ||
| 2026-05-13 | Ryan Barbara Director | Grant or award | +6,518 | 12,242 | ||
| 2026-05-13 | Wheadon David E. Director | Grant or award | +10,430 | 30,780 | ||
| 2026-05-13 | Thompson Juliet Director | Grant or award | +6,518 | 12,973 | ||
| 2026-05-13 | Stejbach Mark Director | Grant or award | +6,518 | 27,087 | ||
| 2026-05-13 | Kingsley Stuart A Director | Grant or award | +6,518 | 12,100 |
Page 8 of 11 · 205 trades